ClearBridge Energy Midstream Opportunity Fund Inc. - Common Stock (EMO)

CUSIP: 18469P209

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 6 signals
Share change
-4,694,747
SEC-reported price per share
$41.22
Number of holders
56
Value change
-$193,290,165
Number of buys
12
Number of sells
52
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
18,189,264

Security key

18469P209

Report period

Q2 2024

Institutions

56

Top holders

10

Ownership snapshot

Top reported holders of EMO - ClearBridge Energy Midstream Opportunity Fund Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Saba Capital Management, ...
Disclosed value leader
Saba Capital Management, ...
Comparable rows
0/15
Latest evidence
31 Mar 2024
13F 3/4/5 Highest disclosed value: $122,119,021 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Saba Capital Management, L.P. has the largest disclosed position value at $122.12M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Saba Capital Management, L.P.'s linked filing trail.
Disclosed position value Top 5
Saba Capital Management, L.P. $122.12M
SIT INVESTMENT ASSOCIATES INC $36.4M
MORGAN STANLEY $25.12M
Raymond James Financial Services ... $15M
Advisors Asset Management, Inc. $9.39M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Saba Capital Management, L.P.
13F 3/4/5
Company · 10%+ Owner
—
denominator unverified
$122,119,021
3,007,117 shares
— 31 Mar 2024
GUARDIAN LIFE INSURANCE CO OF AMERICA
3/4/5
10%+ Owner
—
denominator unverified
—
200,001 shares
— 30 Nov 2022
MASSACHUSETTS MUTUAL LIFE INSURANCE CO
3/4/5
10%+ Owner
—
denominator unverified
—
70 shares
— 17 Nov 2022
SIT INVESTMENT ASSOCIATES INC
13F
Company
13F
—
denominator unverified
$36,395,000
896,205 shares
— 31 Mar 2024
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$25,124,872
618,686 shares
— 31 Mar 2024
Raymond James Financial Services Advisors, Inc.
13F
Company
13F
—
denominator unverified
$15,001,527
369,405 shares
— 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
56
Shares
1,866,653
Rows available
56
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q2 2026 Across Filers

Q2 2026 holders
118
Q2 2024 holders
56
Holder diff
-62
Investor Q2 2026 Shares Q2 2024 Shares Share Diff Share Chg % Q2 2026 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .